Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 3.965
Filtrar
1.
Asian Pac J Cancer Prev ; 25(9): 3209-3217, 2024 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-39342600

RESUMEN

INTRODUCTION: One of the most vexing challenges to public health today is the menace of tobacco. Despite the large body of evidence indicating the vast scale of health hazards, tobacco use continues to be a major cause of preventable death. This study was conducted with the objective of quantifying the progress and challenges of the tobacco control policy of India. METHODS: The Tobacco Control Scale (TCS) was used, which has a maximum score of 100 and assesses nine components including, price of cigarettes, smoke-free public and work places, spending on public information campaigns, comprehensive bans on advertising and promotion, large pictorial health warning labels, treatment to help smokers stop, illicit tobacco trade, tobacco industry interference and ratification of the WHO FCTC. The components of the TCS for India were scored based on data obtained from the WHO, Report on The Global Tobacco Epidemic, 2021 and the Cigarettes and Other Tobacco Products Act 2003 and their amendments and the Tobacco India 2023 country profile. RESULTS: The total score for the tobacco control scale placed India at 65 points, scoring highest with respect to 'large pictorial health warning labels', and lower with respect to 'spending on public information campaigns', 'illicit tobacco trade' and 'price of cigarettes'. CONCLUSIONS: Strong tobacco control legislation and its equally robust implementation is an affirmative step in achieving the vision of the WHO-FCTC and empowering the world towards being tobacco free.


Asunto(s)
Prevención del Hábito de Fumar , Industria del Tabaco , Productos de Tabaco , Humanos , India/epidemiología , Industria del Tabaco/legislación & jurisprudencia , Prevención del Hábito de Fumar/métodos , Prevención del Hábito de Fumar/legislación & jurisprudencia , Productos de Tabaco/legislación & jurisprudencia , Política de Salud , Salud Pública/legislación & jurisprudencia , Cese del Hábito de Fumar/legislación & jurisprudencia , Fumar/epidemiología , Fumar/legislación & jurisprudencia , Fumar/efectos adversos , Política para Fumadores/legislación & jurisprudencia , Control del Tabaco
5.
Asia Pac J Public Health ; 36(6-7): 619-627, 2024 09.
Artículo en Inglés | MEDLINE | ID: mdl-39192573

RESUMEN

Smoke-free laws (SFL) are more effective with public support. This study investigated the smoking prevalence, public perceptions of smoking rules, and support for comprehensive SFL among 1047 people who smoke (PWS) and 206 people who do not smoke (PNS) aged ≥18 in the 2020 International Tobacco Control Malaysia Survey. Smoking prevalence was highest in nighttime entertainment venues (85.7%), non-air-conditioned eateries (49.7%), and indoor workplaces (34.6%). Respondents reported that smoking was banned in most indoor workplaces (81.7% PNS, 69.2% PWS), air-conditioned eateries (84.7% PNS, 75.7% PWS), and non-air-conditioned eateries (81.2% PNS, 78.7% PWS), but much less so in nighttime entertainment venues (30.1% PNS, 24.6% PWS). Support for comprehensive SFL in public venues was highest among PNS (≥84.9%) but still substantial among PWS (≥49.9%). PWS under 40, Malay, married, and aware of smoking rules supported SFL more. Robust SFL enforcement is essential in Malaysia to reduce secondhand smoke exposure in public places.


Asunto(s)
Política para Fumadores , Humanos , Malasia/epidemiología , Adulto , Masculino , Femenino , Política para Fumadores/legislación & jurisprudencia , Persona de Mediana Edad , Adulto Joven , Adolescente , Opinión Pública , Encuestas y Cuestionarios , Contaminación por Humo de Tabaco/legislación & jurisprudencia , Contaminación por Humo de Tabaco/prevención & control , Contaminación por Humo de Tabaco/estadística & datos numéricos , Prevalencia , Anciano , Fumar/legislación & jurisprudencia , Fumar/epidemiología
6.
Health Policy ; 147: 105123, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-39018787

RESUMEN

For several decades, Aotearoa New Zealand has maintained a relatively strict regulatory approach towards tobacco. In response to the significant impact of tobacco-related illnesses, many countries worldwide have worked to enhance tobacco control measures. These efforts include introducing plain tobacco packaging with graphic health warnings, improving access to smoking cessation services and offering supportive treatments for tobacco dependence. In December 2022, New Zealand enacted world-leading tobacco control legislation aimed at leading the nation towards a 'smokefree' future by 2025, a future where the smoking prevalence falls below 5 percent across all population groups. To achieve this goal, revolutionary measures were needed. These measures included denicotinising cigarettes, reducing the number of tobacco retail outlets, and implementing a generational ban on smoked products. Despite receiving support from academics, clinicians, leaders of local indigenous communities, and the general public, the sixth National-led coalition government remained resolute in repealing the law and did so through parliamentary urgency on 27 February 2024. The reversal of this health policy is anticipated to result in thousands of lives lost and widen life expectancy gaps between indigenous and non-indigenous populations. This decision, driven by political agenda objectives and interference from the tobacco industry, has not only impeded New Zealand's progress but also weakened global efforts in tobacco control.


Asunto(s)
Productos de Tabaco , Nueva Zelanda/epidemiología , Humanos , Productos de Tabaco/legislación & jurisprudencia , Política para Fumadores/legislación & jurisprudencia , Cese del Hábito de Fumar/métodos , Cese del Hábito de Fumar/legislación & jurisprudencia , Política de Salud , Prevención del Hábito de Fumar , Fumar/legislación & jurisprudencia , Fumar/epidemiología
7.
Artículo en Alemán | MEDLINE | ID: mdl-38834931

RESUMEN

The consumption of tobacco continues to be the greatest preventable health risk in Germany. Every year, more than 127,000 people die prematurely as a result of using tobacco - one in five new cases of cancer is a consequence of smoking. Germany's current tobacco control policy, consisting of advertising bans, the promotion of smoke-free environments, and an abstinence-only paradigm, are only able to initiate slow change. Other countries have shown how the number of smokers can be reduced and deaths prevented by integrating harm reduction as a complementary measure and providing a much more active support for people who want to quit. This article first presents the current situation and current measures in Germany. Then recommendations for changes to the current tobacco control policy in Germany are derived from a look at the United Kingdom, which is considered a pioneer throughout Europe with its tobacco control policy, as well as a summary of the current state of research.


Asunto(s)
Reducción del Daño , Política de Salud , Cese del Hábito de Fumar , Prevención del Hábito de Fumar , Alemania , Humanos , Política de Salud/legislación & jurisprudencia , Prevención del Hábito de Fumar/legislación & jurisprudencia , Cese del Hábito de Fumar/legislación & jurisprudencia , Política para Fumadores/legislación & jurisprudencia , Fumar/legislación & jurisprudencia , Fumar/epidemiología , Control del Tabaco
8.
Global Health ; 20(1): 40, 2024 May 07.
Artículo en Inglés | MEDLINE | ID: mdl-38715053

RESUMEN

BACKGROUND: In response to the harm caused by tobacco use worldwide, the World Health Organization (WHO) World Health Assembly actioned the WHO Framework Convention on Tobacco Control (FCTC) in 2005. To help countries meet their FCTC obligations, the WHO introduced in 2008 the MPOWER policy package and by 2020 the FCTC had been ratified by 182 parties. The package consists of six evidence-based demand reduction smoking cessation policies to assist countries to achieve best practice. We used published evaluation results and replicated the published model to estimate current policy achievement and demonstrate the impact and equity of the MPOWER policy package in reducing the global number of smokers and smoking-attributable deaths (SADs) between 2007 and 2020. METHODS: We replicated an evaluation model (the Abridged SimSmoke model) used previously for country impact assessments and validated our replicated reduction in SADs for policies between 2014 and 2016 against the published results. The replicated model was then applied to report on the country level SADs averted from achieving the highest level of implementation, that is best practice in MPOWER policies, between 2016 and 2020. The latest results were then combined with past published results to estimate the reduction in SADs since the commencement of the MPOWER policy package. Country level income status was used to investigate the equity in the uptake of MPOWER policies worldwide. RESULTS: Identical estimates for SADs in 41 out of 56 MPOWER policies implemented in 43 countries suggested good agreement in the model replication. The replicated model overestimated the reduction in SADs by 159,800 (1.5%) out of a total of 10.5 million SADs with three countries contributing to the majority of this replication discrepancy. Updated analysis estimated a reduction of 8.57 million smokers and 3.37 million SADs between 2016 and 2020. Between 2007 and 2020, 136 countries had adopted and maintained at least one MPOWER policy at the highest level which was associated with a reduction in 81.0 million smokers and 28.3 million SADs. Seventy five percent of this reduction was in middle income countries, 20% in high income and less than 5% in low income countries. CONCLUSIONS: Considerable progress has been made by MPOWER policies to reduce the prevalence of smokers globally. However, there is inequality in the implementation and maintenance, reach and influence, and the number of SADs averted. Future research to modify the model could provide a more comprehensive evaluation of past and future progress in tobacco control policies, worldwide.


Asunto(s)
Salud Global , Política de Salud , Cese del Hábito de Fumar , Organización Mundial de la Salud , Humanos , Cese del Hábito de Fumar/legislación & jurisprudencia , Fumar/legislación & jurisprudencia , Fumar/epidemiología , Prevención del Hábito de Fumar/legislación & jurisprudencia
10.
J Public Health Policy ; 45(2): 378-392, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38575787

RESUMEN

This study aims to determinate the correlation between tobacco control policies (TCP) and the prevalence of tobacco use in the 32 Mexican states during the 2016-2017 period. This is an ecological study that measured TCP by the Tobacco Control Scale (TCS) which assigns a score (0-100) based on the level of these component's implementation: price, prohibition in public spaces, expenditures of public information campaigns, publicity prohibitions, health warnings, and treatments. We analyzed the associations between the TCS scores and prevalence of tobacco use extracted from the National Survey of Drug, Alcohol and Tobacco Consumption using Spearman correlations. Prevalence of daily smokers is negatively correlated with global TCS scores for adolescents (p = 0.026). Price showed similar negative correlations with daily prevalence in adolescents (p = 0.003), adults (p = 0.040), men (p < 0.006), and women (p = 0.040). Many Mexican states need to improve on tobacco control policies, especially targeting a key population: adolescents.


Asunto(s)
Política de Salud , Prevención del Hábito de Fumar , Humanos , México/epidemiología , Adolescente , Masculino , Femenino , Adulto , Prevención del Hábito de Fumar/legislación & jurisprudencia , Uso de Tabaco/prevención & control , Uso de Tabaco/epidemiología , Uso de Tabaco/legislación & jurisprudencia , Prevalencia , Adulto Joven , Persona de Mediana Edad , Fumar/epidemiología , Fumar/legislación & jurisprudencia , Control del Tabaco
11.
Public Health Res Pract ; 34(1)2024 Apr 04.
Artículo en Inglés | MEDLINE | ID: mdl-38569574

RESUMEN

OBJECTIVES: People living in subsidised low-income housing are more likely to smoke and experience secondhand smoke exposure compared to the general population. While tobacco control interventions have yielded substantial population health benefits, people living in subsidised housing experience a greater burden of tobacco-related harms. We synthesised existing peer-reviewed and grey literature to determine tobacco control interventions that have been implemented in subsidised housing globally, and to understand their impact on smoking and secondhand smoke exposure. METHODS: We searched five databases for peer-reviewed research, and Google Advanced for grey literature. We adhered to the JBI Scoping Review Methodology and Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist. RESULTS: Fifty-seven sources met the eligibility criteria. The most common type of intervention was mandatory smoking bans covering all indoor spaces (n = 32), followed by cessation-focused interventions (n = 19). Interventions that indirectly addressed smoking were the least common (n = 6). Our findings suggest smoking bans can increase smoking cessation and reduce secondhand smoke exposure, especially if implemented alongside cessation support strategies. CONCLUSION: Tobacco control interventions targeting subsidised housing demonstrate positive effects on tobacco-related outcomes for residents and provide an important opportunity to address health disparities. Future research should examine the long-term impacts of the interventions, including potential unintended consequences, in varied subsidised housing contexts.


Asunto(s)
Pobreza , Control del Tabaco , Contaminación por Humo de Tabaco , Humanos , Vivienda Popular/legislación & jurisprudencia , Vivienda Popular/organización & administración , Fumar/epidemiología , Fumar/legislación & jurisprudencia , Cese del Hábito de Fumar/métodos , Control del Tabaco/legislación & jurisprudencia , Contaminación por Humo de Tabaco/prevención & control
12.
Soc Sci Med ; 348: 116875, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38613870

RESUMEN

In 2011, China implemented tougher driving-under-the-influence laws, which criminalized driving under the influence of alcohol for the first time and increased penalties. This paper provides the first comprehensive analysis of the effects of stricter drinking policies on men's smoking behavior by using data from the 2010 and 2012 waves of the China Family Panel Studies. The results show that stricter drinking policies reduced smoking initiation and the number of cigarettes smoked per day among men by reducing the frequency and quantity of alcohol consumption. Heterogeneity analyses show that the impact of the policy is more pronounced not only for men aged 41-55, but also for men who have higher educational qualifications, who are employed, or who are not members of the Communist Party.


Asunto(s)
Consumo de Bebidas Alcohólicas , Fumar , Humanos , Masculino , China/epidemiología , Adulto , Consumo de Bebidas Alcohólicas/legislación & jurisprudencia , Consumo de Bebidas Alcohólicas/epidemiología , Consumo de Bebidas Alcohólicas/psicología , Persona de Mediana Edad , Fumar/epidemiología , Fumar/legislación & jurisprudencia , Fumar/psicología , Adulto Joven , Adolescente , Conducir bajo la Influencia/estadística & datos numéricos , Conducir bajo la Influencia/legislación & jurisprudencia , Política Pública
13.
Tob Control ; 33(Suppl 2): s38-s43, 2024 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-38443163

RESUMEN

BACKGROUND: Albania has one of the highest smoking prevalence in Europe especially among the youth. There is a lack of evidence in Albania, as well as in most of Eastern Europe and middle-income countries, regarding the effect of price on smoking experimentation. OBJECTIVE: The study aims to assess the effect of price and tobacco control policies on youth smoking experimentation in Albania. METHODS: We used microdata from the Global Youth Tobacco Survey in Albania for 2004, 2009, 2015 and 2020. We constructed a pseudo-longitudinal dataset and estimated a split-population model to assess the hazard of smoking experimentation. RESULTS: Price is a significant predictor of smoking experimentation among teenagers in Albania for both males and females (p<0.001). Being male increases the odds for smoking experimentation by more than 50% as compared with females (p<0.001), whereas females appear to be more price sensitive. Peer and parent smoking are also important determinants for smoking experimentation. Introducing penalties for smokers and legal entities violating smoke-free policies implemented in 2014 is also associated with a lower hazard of smoking experimentation. CONCLUSION: Price is a significant predictor of smoking experimentation among teenagers in Albania for both males and females. A combination of increasing taxes and strengthening the rule of law to control tobacco use in public spaces, in addition to public awareness campaigns targeting both youth and smoking parents, could help to significantly reduce the probability of smoking experimentation.


Asunto(s)
Comercio , Productos de Tabaco , Humanos , Albania/epidemiología , Adolescente , Masculino , Femenino , Productos de Tabaco/economía , Productos de Tabaco/legislación & jurisprudencia , Comercio/legislación & jurisprudencia , Comercio/estadística & datos numéricos , Comercio/economía , Política para Fumadores/legislación & jurisprudencia , Impuestos/legislación & jurisprudencia , Impuestos/economía , Prevalencia , Factores Sexuales , Fumar/economía , Fumar/epidemiología , Fumar/legislación & jurisprudencia , Conducta del Adolescente , Encuestas y Cuestionarios , Control del Tabaco
14.
Nicotine Tob Res ; 26(9): 1166-1174, 2024 Aug 22.
Artículo en Inglés | MEDLINE | ID: mdl-38457437

RESUMEN

INTRODUCTION: The harmful effects of first and secondhand smoking are well-established. Smoke-free laws aim at protecting nonsmokers. This study aimed to assess the impact of the 2013 total ban on indoor smoking in Chile on hospitalizations and deaths of major cardiovascular events. AIMS AND METHODS: The logarithm of the monthly hospitalization and death rates, standardized by age for every 100 000 inhabitants, were estimated for ischemic heart disease, acute myocardial infarction, strokes, and a composite outcome of ischemic heart diseases (which includes acute myocardial infarction) and strokes. In addition, interrupted time series with synthetic control groups were used to assess changes in levels and trends after the intervention. RESULTS: The total ban on indoor smoking caused significant reductions in death rates for the three diseases studied for age groups above 20 years old. In addition, there were substantial decreases in the post-intervention hospitalization rates for ischemic heart disease: for the 20-44 age group, the decrease was 8.7% compared to the pre-intervention period (p < .01). In comparison, such a reduction was 4% (p < .01) for the ≥65 age group. For acute myocardial infarction, the decrease was 11.5% (p < .01) for the 20-44 age group, while for stroke, it was a 1.2% (p < .01) decrease for the total population. It is estimated that the smoking ban averted 15.6% of the deaths compared with the synthetic control groups. CONCLUSIONS: The implementation of total smoke-free environments in Chile contributed to the reduction of mortality for main cardiovascular diseases. This study provides additional evidence of causality linking the policy to health outcomes. IMPLICATIONS: The total indoor smoking ban significantly affected age-standardized hospitalization and deaths. The number of deaths averted by this policy is estimated at approximately 4758 and 5256 for IHD and stroke, respectively, during the 2013-2017 period (15.6% fewer deaths than predicted by the synthetic control groups). The study contributes to the body of evidence that supports total indoor smoking bans.


Asunto(s)
Enfermedades Cardiovasculares , Hospitalización , Contaminación por Humo de Tabaco , Humanos , Chile/epidemiología , Hospitalización/estadística & datos numéricos , Adulto , Persona de Mediana Edad , Contaminación por Humo de Tabaco/prevención & control , Contaminación por Humo de Tabaco/legislación & jurisprudencia , Contaminación por Humo de Tabaco/efectos adversos , Enfermedades Cardiovasculares/mortalidad , Enfermedades Cardiovasculares/prevención & control , Anciano , Masculino , Femenino , Adulto Joven , Política para Fumadores/legislación & jurisprudencia , Infarto del Miocardio/mortalidad , Infarto del Miocardio/epidemiología , Infarto del Miocardio/prevención & control , Fumar/legislación & jurisprudencia , Fumar/epidemiología , Accidente Cerebrovascular/mortalidad , Accidente Cerebrovascular/prevención & control
15.
Clin Transl Oncol ; 26(7): 1561-1569, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38347375

RESUMEN

Smoking and exposure to secondhand smoke pose a significant risk to the health of populations. Although this evidence is not new, the commitment of countries to implement laws aimed at controlling consumption and eliminating exposure to secondhand smoke is uneven. Thus, in North America or in Europe, locations like California or Ireland, are pioneers in establishing policies aimed at protecting the population against smoking and secondhand smoke. Identifying measures that have worked would help control this important Public Health problem in other countries that are further behind in tobacco control policies. In Spain, there has been almost 15 years of little political action in legislation oriented to control the tobacco epidemic. If we want to achieve the tobacco endgame, new legislative measures must be implemented. In this paper, we have elucidated tobacco control policies that could be implemented and show how different countries have done so.


Asunto(s)
Política de Salud , Contaminación por Humo de Tabaco , Humanos , España/epidemiología , Contaminación por Humo de Tabaco/prevención & control , Contaminación por Humo de Tabaco/legislación & jurisprudencia , Contaminación por Humo de Tabaco/efectos adversos , Política de Salud/legislación & jurisprudencia , Fumar/legislación & jurisprudencia , Fumar/epidemiología , Fumar/efectos adversos , Prevención del Hábito de Fumar/legislación & jurisprudencia , Cese del Hábito de Fumar/legislación & jurisprudencia , Política para Fumadores/legislación & jurisprudencia , Control del Tabaco
16.
Laryngorhinootologie ; 103(10): 723-727, 2024 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-38408485

RESUMEN

BACKGROUND: With the aim of protecting minors, the World Health Organization has recommended classifying films with smoking scenes as unsuitable for children and adolescents. In recent years, films have increasingly been viewed via video streaming services - a trend which has been intensified by the COVID-19 pandemic - which poses new challenges for the protection of minors. AIM: To examine the frequency of smoking scenes in Netflix feature films and the age recommendations for Netflix productions with smoking scenes. METHOD: A total of 235 films that were made available for streaming exclusively by the Netflix platform in 2021 and 2022 were content coded in order to find out (1) how high the proportion of smoke-free films was in this film sample, (2) how often smoking scenes occurred in these films and (3) the proportion of films with smoke scenes classified as appropriate for young people in Germany and the USA. All films with an age rating of under 16 were considered suitable for children and young people. RESULTS: Smoking scenes occurred in 113 of 235 analyzed films (48.1%). Of the 113 films with smoking scenes, 57 (50.4%) in Germany and 26 films (23.0%) in the USA were classified as youth films (p<0.001). A total of 3,310 smoking scenes were registered. Of these, 39.4% (n=1,303) were in films with youth ratings in Germany, and in Netflix USA this proportion was 15.8% (n=524). DISCUSSION: Smoking scenes are a common feature in Netflix movies. Neither in the US nor in Germany does Netflix adhere to the recommendations of the WHO Framework Convention on Tobacco Control to restrict access by young people to films depicting smoking. However, the protection of minors in the US is better than in Germany, since half of the Netflix films with smoking scenes in Germany were rated as suitable for minors, in the USA less than a quarter.


Asunto(s)
COVID-19 , Películas Cinematográficas , Humanos , Adolescente , Niño , Alemania , COVID-19/prevención & control , COVID-19/epidemiología , Estados Unidos , Fumar/epidemiología , Fumar/legislación & jurisprudencia , SARS-CoV-2 , Pandemias/prevención & control
17.
N Z Med J ; 136(1579): 49-61, 2023 Jul 21.
Artículo en Inglés | MEDLINE | ID: mdl-37501244

RESUMEN

AIM: The recently passed Smokefree Environments and Regulated Products (Smoked Tobacco) Amendment Act has the potential to profoundly reduce smoking prevalence and related health inequities experienced among Maori. This study examined support for, and potential impacts of, key measures included within the legislation. METHOD: Data came from Wave 1 (2017-2019) of the Te Ara Auahi Kore longitudinal study, which was conducted in partnership with five primary health organisations serving Maori communities. Participants were 701 Maori who smoked. Analysis included both descriptive analysis and logistic regression. RESULTS: More Maori participants supported than did not support the Smokefree 2025 (SF2025) goal of reducing smoking prevalence to below 5%, and the key associated measures. Support was greatest for mandating very low nicotine cigarettes (VLNCs). Participants also believed VLNCs would prompt high rates of quitting. Participants who had made more quit attempts or reported less control over their life were more likely to support VLNCs. CONCLUSION: There was support for the SF2025 goal and for key measures that could achieve it. In particular, VLNCs may have significant potential to reduce smoking prevalence among Maori. As part of developing and implementing these measures it will be important to engage with Maori who smoke and their communities.


Asunto(s)
Fumar Cigarrillos , Pueblo Maorí , Cese del Hábito de Fumar , Contaminación por Humo de Tabaco , Humanos , Estudios Longitudinales , Pueblo Maorí/estadística & datos numéricos , Nueva Zelanda/epidemiología , Fumar/efectos adversos , Fumar/epidemiología , Fumar/etnología , Fumar/legislación & jurisprudencia , Productos de Tabaco/legislación & jurisprudencia , Productos de Tabaco/estadística & datos numéricos , Cese del Hábito de Fumar/legislación & jurisprudencia , Cese del Hábito de Fumar/métodos , Contaminación por Humo de Tabaco/legislación & jurisprudencia , Contaminación por Humo de Tabaco/prevención & control , Fumar Cigarrillos/efectos adversos , Fumar Cigarrillos/etnología , Fumar Cigarrillos/legislación & jurisprudencia , Fumar Cigarrillos/prevención & control
18.
Artículo en Inglés | MEDLINE | ID: mdl-36901524

RESUMEN

This study evaluates the association between smoking rates and mortality from circulatory system diseases (CSD) after implementing a series of smoking bans in Macao (China). (1) Background: Macao phased in strict total smoking bans since 2012. During the past decade, smoking rates among Macao women have dropped by half. CSD mortalities in Macao also show a declining trend. (2) Method: Grey relational analysis (GRA) models were adopted to rank the importance of some key factors, such as income per capita, physician density, and smoking rates. Additionally, regressions were performed with the bootstrapping method. (3) Results: Overall, smoking rate was ranked as the most important factor affecting CSD mortality among the Macao population. It consistently remains the primary factor among Macao's female population. Each year, on average 5 CSD-caused deaths were avoided among every 100,000 women, equivalent to about 11.45% of the mean annual CSD mortality. (4) Conclusions: After the implementation of smoking bans in Macao, the decrease in smoking rate among women plays a primary role in the reduction in CSD mortality. To avoid excess CSD mortality due to smoking, Macao needs to continue to promote smoking cessation among the male population.


Asunto(s)
Enfermedades Cardiovasculares , Política para Fumadores , Femenino , Humanos , Masculino , Enfermedades Cardiovasculares/mortalidad , Sistema Cardiovascular , China , Macao/epidemiología , Política para Fumadores/legislación & jurisprudencia , Fumar/epidemiología , Fumar/legislación & jurisprudencia
20.
Science ; 378(6626): 1268-1271, 2022 12 23.
Artículo en Inglés | MEDLINE | ID: mdl-36548415
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA